|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-10-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Idiopathic pulmonary fibrosis is a progressive lung disease with a high mortality rate. Because the signaling pathways activated by several tyrosine kinase receptors have been shown to be involved in lung fibrosis, it has been suggested that the inhibition of these receptors may slow the progression of idiopathic pulmonary fibrosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BrownKevin KKK,
pubmed-author:BrunMichèleM,
pubmed-author:CostabelUlrichU,
pubmed-author:FlahertyKevin RKR,
pubmed-author:GuptaAbhyaA,
pubmed-author:HansellDavid MDM,
pubmed-author:JuhelNolwennN,
pubmed-author:KimDong SoonDS,
pubmed-author:KlüglichMatthiasM,
pubmed-author:NicholsonAndrew GAG,
pubmed-author:NoblePaul WPW,
pubmed-author:RaghuGaneshG,
pubmed-author:RicheldiLucaL,
pubmed-author:SelmanMoisesM,
pubmed-author:du BoisRoland MRM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
22
|
|
pubmed:volume |
365
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1079-87
|
|
pubmed:meshHeading |
pubmed-meshheading:21992121-Adult,
pubmed-meshheading:21992121-Aged,
pubmed-meshheading:21992121-Alanine Transaminase,
pubmed-meshheading:21992121-Aspartate Aminotransferases,
pubmed-meshheading:21992121-Enzyme Inhibitors,
pubmed-meshheading:21992121-Female,
pubmed-meshheading:21992121-Humans,
pubmed-meshheading:21992121-Idiopathic Pulmonary Fibrosis,
pubmed-meshheading:21992121-Indoles,
pubmed-meshheading:21992121-Liver,
pubmed-meshheading:21992121-Male,
pubmed-meshheading:21992121-Middle Aged,
pubmed-meshheading:21992121-Protein-Tyrosine Kinases,
pubmed-meshheading:21992121-Vital Capacity
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
|
|
pubmed:affiliation |
Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy. luca.richeldi@unimore.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
